Clinical Trials Logo

Clinical Trial Summary

This is a two-centers, open label, prospective, randomized, noninferiority controlled trial with cost-effectiveness analysis to verify if is non inferior to remove peripheral intravenous catheter according to clinical signs in relation to every 96 hours.


Clinical Trial Description

The care practice standards related to infusion therapy (IT) are stipulated and regulated by US institutions, such as the Infusion Nurses Society (INS) and the Center for Disease and Control (CDC), and, in Brazil, by the Brazilian National Health Surveillance Agency (ANVISA). Within this topic, the investigators can mention peripherally administered IT through peripheral intravenous catheters (PIC) as the most used one, since this is less complex and less invasive, and it offers a lower risk of severe complications compared to central line IT.

PIC placement, maintenance and removal procedures are not free of complications, and in order to prevent them, regulatory agencies publish formal recommendations. One of these refers to the time the PIC remains at the same site (residence time), which has been determined to be 96 hours for the adult population, i.e., it should be removed and punctured again at another site, systematically, even if not showing any inflammatory sign within 96 hours.

Following literature review, one can see that these recommendations are based on limited evidence, and supported by data from old studies. For this reason, the investigators discuss if employing a systematic and elective change procedure for adults would be the best option, as the investigators have taken some aspects into consideration, such as: Patient safety - The PIC dwell time at the placement site, as shown by research results, has increased throughout the decades to 24, 48, 72, and 96 hours. If the PIC change is performed on a child who, theoretically, is a less immune-competent patient as compared to adults, this is performed according to clinical signs, then the investigators can conclude that adopting the same procedure for adults would be safe. Peripheral venous depletion - Logic leads us to consider that the less the investigators puncture a patient, more access is available, and less outcomes with IT-specific complications occur. Patient satisfaction - With reduced exposures to painful and invasive events, the patient will also benefit from it. Few patients refrain from showing dissatisfaction when the PIC is to be placed again electively. Quality - Producing scientific evidence and adopting the best practices in hospital environments is practicing quality. Economic aspects - If these PIC changes were less frequent, they would necessarily imply less spending with inputs and devices, as well as less time spent by the team performing the procedure, which represents less cost and workload. Occupational safety - Studies show an estimated relationship between the occurrence of an accident with biological material and performing invasive procedures. Reducing the number of punctures performed by a professional, in addition to decreasing the workload, may reduce the exposure to risk and accidents.

Research studies carried out mostly in Australia aim at showing that the systematic PIC removal and change do not bring benefits, when compared to change based on clinical manifestations. However, a systematic review study in 2010 did not find conclusive evidence, and suggested the development of other projects in several regions, of different natures and realities, so as to further mature the hypothesis. To support this, the INS has also formally stated that this theme is a research priority at this time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02568670
Study type Interventional
Source Federal University of São Paulo
Contact
Status Completed
Phase N/A
Start date November 2015
Completion date September 2016

See also
  Status Clinical Trial Phase
Completed NCT00989599 - Use of Chamomilla Recutita in Phlebitis Phase 3
Completed NCT05714137 - Reducing the Risk of Phlebitis From Peripheral Venous Catheter N/A
Not yet recruiting NCT04127149 - Evaluation of Ultra-portable Ultrasound in General Practice N/A
Completed NCT00670540 - Epidemiology of Thromboembolism Disease: A Cohort Study N/A
Recruiting NCT06030141 - Investigation of the Effect of Nigella Sativa Oil and Sesame Oil in Preventing Phlebitis N/A
Completed NCT03193827 - In-line Filtration Reduces Postoperative Phlebitis. N/A
Completed NCT04569474 - Peripheral IV Dressing and Phlebitis in Patients From Amazon N/A
Completed NCT01943006 - Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis Phase 3
Terminated NCT00418470 - Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People Phase 4
Active, not recruiting NCT00103636 - Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change Phase 2/Phase 3
Completed NCT05058053 - THE EFFECT OF COLD APPLICATION ON THE DEVELOPMENT OF PHLEBITIS IN PATIENTS RECEIVING INTRAVENOUS AMIODARONE TREATMENT. N/A
Completed NCT01131754 - Heparin 100U/L for Prevention of PVC Complications Phase 3
Not yet recruiting NCT05870449 - The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications N/A
Suspended NCT01794767 - Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children Phase 4
Completed NCT04817020 - Effect of Skin Antisepsis on Phlebitis N/A
Completed NCT05226312 - Phlebitis Care and Warm Wet Application N/A
Terminated NCT04218643 - Ultrasound-guided Peripheral Intravenous Catheter Insertion Technique N/A
Not yet recruiting NCT04685031 - Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis Phase 1/Phase 2
Completed NCT06216522 - The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults N/A